Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 17, 2003. The report details a specific corporate action regarding share re-purchases executed in accordance with shareholder authority granted at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share re-purchase transaction:
- Shares Purchased: 1,200,000 Ordinary 25 pence shares.
- Purchase Date: June 16, 2003.
- Purchase Price: 1,242.67 pence per share.
- Transaction Purpose: Cancellation of shares.
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 1,200,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a procedural announcement of a completed share buyback.
Investor Verification Checklist
- Verify the total number of shares authorized for re-purchase at the May 19, 2003 Annual General Meeting to determine remaining buyback capacity.
- Confirm the total cost of the transaction (1,200,000 shares x 1,242.67 pence) against the company's cash reserves or debt facilities.
- Check subsequent filings to see if this was part of a larger, ongoing re-purchase program.